BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1022 related articles for article (PubMed ID: 12942032)

  • 21. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia].
    Jiang NG; Zhu HL; Zeng TT; Su J; Zhang Y; Jia YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):664-8. PubMed ID: 20848792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single step immunophenotyping of acute leukemias not classifiable by standard morphology and cytochemistry: a practical approach.
    Raimondi R; Pellizzari G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):66-72. PubMed ID: 8039763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of intracellular lymphoid differentiation antigens by flow cytometry in acute lymphoblastic leukemia.
    Sartor M; Bradstock K
    Cytometry; 1994 Sep; 18(3):119-22. PubMed ID: 7813331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
    van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
    J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O; Glasová M; Koníková E; Kusenda J
    Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic subtyping of leukemic cells from Iranian patients with acute lymphoblastic leukaemia: association to disease outcome.
    Asgarian Omran H; Shabani M; Shahrestani T; Sarafnejad A; Khoshnoodi J; Vossough P; Faranoush M; Sharifian RA; Jeddi-Tehrani M; Rabbani H; Shokri F
    Iran J Immunol; 2007 Mar; 4(1):15-25. PubMed ID: 17652839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between argyrophilic proteins and some immunophenotypic markers in acute leukemia cells.
    Klobusická M; Babusíková O
    Neoplasma; 1997; 44(6):356-60. PubMed ID: 9605007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.